Comprehensive review highlights Aloe vera’s versatile biological activities and its potential applications in medicine and cosmetics while addressing its safety concerns.
FDA approves Daiichi Sankyo’s acute myeloid leukaemia treatment
Vanflyta is claimed to be the first and only FLT3 inhibitor to receive FDA approval for treating FLT3-ITD positive AML. Credit: Nemes Laszlo / Shutterstock.com.